Pharmafile Logo

New syndicated patient reports –

September 7, 2022 | Living with, Patient reports, Syndicated 

Living with Uterine Fibroids and Endometriosis US 2022

Living with Uterine Fibroids (UF) and Endometriosis (Endo) are new patient syndicated reports which offer valuable insights into patient attitudes and behaviour towards their condition, treatments and unmet needs. These reports provide pharmaceutical companies with a strong, foundational knowledge and up-to-date insights on the UF and Endo patient journeys.

UF and Endo place a similar burden on women, their family and employment opportunities. Women’s health is starting to be discussed more widely, so necessary conversations are beginning to open up meaning more women are likely to seek HCP advice and treatment. The Living with UF and Endo reports have been conducted to help pharma identify how patients truly feel, perception of their current treatment options and unmet needs.

Both reports cover the US market, Living with UF (sample of 110 patients) and Living with Endo (sample of 111 patients). The methodologies consisted of 40-minute quantitative online interviews and a small sample of 40-minute qualitative telephone interviews, including patient diary tasks 1 week before the interviews.

Research Partnership has also recently launched new US reports in Living with CKD, PsA, Ankylosing Spondylitis. To find out more about these new reports or to request an information pack please contact us now.

Head of Living With, Mariel Metcalfe commented, “Research Partnership is committed to producing research which focuses on the voice of the patient, and to offer a more patient-centric view of what it is like to live with a long-term, life-changing illness. Our reports cover a wide range of therapy areas from Autoimmune, Dermatology and Gastroenterology, and we hope to expand the list of therapy areas year on year.”

Find out more about Living With here

This content was provided by Research Partnership

Company Details

 Latest Content from  Research Partnership 

Research Partnership is UK’s fastest growing healthcare market research specialist

The latest league tables for the UK market research industry have just been released and reveal Research Partnership to be the fastest growing healthcare market research specialist for 2014.With turnover...

Emerging Markets: Your Essential Guide

Using our combined knowledge and years of experience of working in these territories, our experts have produced an essential guide to help address some of the core challenges for conducting market...

Free Thinking: From promise to practice: immuno-oncology in action

This white paper explores the global outlook for new immunotherapy products, referencing key opinion leaders and payers to investigate how these products are faring both clinically and financially. Immuno-oncology therapies that...

Exploring the Opportunity For Halal In Healthcare

Published in Medical Marketing & Media November 2015

Case study: Opportunity Assessment for a Rare Disease Product in Emerging Markets

Using in-depth-interviews to determine how to maximise the commercial opportunities in different emerging markets

12 Challenges Big Pharma Faces in China

Published in eyeforpharma 16 November by Rachel Howard

Using mobile “diary” research to capture patient-generated insights in COPD

Our latest case study demonstrates how a mobile app methodology was used to deliver key insights into issues faced by COPD patients

Biosimilars in 2018: EU doctors’ perceptions of RA drug market

Published in pharmaphorum October 2015 by Laurent Chanroux

Webinar: Understanding the Patient Journey in China 2015

Utilising local knowledge and detailed case studies, this webinar examines the likely impact on the patient journey and consider the possible implications for market researchers.

Understanding Patient Willingness to Pay

Published in eyeforpharma 12 October by Rachel Howard